» Authors » Lily Ingsrisawang

Lily Ingsrisawang

Explore the profile of Lily Ingsrisawang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 121
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Khemthong S, Luenam P, Frank T, Ingsrisawang L
PLoS One . 2024 Aug; 19(8):e0308153. PMID: 39088475
The study examined the determinants that affect tourism receipts in Thailand. To this end, quarterly data from eight main provinces of Thailand from the period 2015-2019 were used and constituted...
2.
Harnpicharnchai P, Siriarchawatana P, Mayteeworakoon S, Ingsrisawang L, Likhitrattanapisal S, Eurwilaichitr L, et al.
Environ Res . 2024 Jan; 247:118269. PMID: 38246293
Investigating the quality of the subway environment, especially regarding antibiotic resistance genes (ARGs) and xenobiotics, conveys ecological and health impacts. In this study, compositions and relations of microorganisms harboring ARGs...
3.
Harnpicharnchai P, Pumkaeo P, Siriarchawatana P, Likhitrattanapisal S, Mayteeworakoon S, Ingsrisawang L, et al.
PLoS One . 2023 Jun; 18(6):e0287567. PMID: 37384659
Analyzing temporal and spatial distributions of airborne particles of biological origins is vital for the assessment and monitoring of air quality, especially with regard to public health, environmental ecology, and...
4.
Varapongpisan T, Frank T, Ingsrisawang L
PLoS One . 2022 Aug; 17(8):e0272995. PMID: 35980887
Chiang Mai is one of the most known cities of Northern Thailand, representative for various cities in the East and South-East Asian region exhibiting seasonal smog crises. While a few...
5.
Homkham N, Cressey T, Bouazza N, Ingsrisawang L, Techakunakorn P, Mekmullica J, et al.
PLoS One . 2019 May; 14(5):e0216868. PMID: 31095608
Background: To access the long term relationship between efavirenz plasma concentrations and evolution of HIV RNA loads and CD4 cell counts in children. Methods: Retrospective analysis of data from HIV-infected...
6.
Kumluang S, Ingsrisawang L, Sangroongruangsri S, Chaikledkaew U, Ratanapakorn T, Ruamviboonsuk P, et al.
BMC Ophthalmol . 2019 Mar; 19(1):82. PMID: 30922350
Background: To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand. Methods: A prospective, multi-centre, observational study...
7.
Sangroongruangsri S, Chaikledkaew U, Kumluang S, Wu O, Geue C, Ratanapakorn T, et al.
Clin Drug Investig . 2019 Jan; 39(1):115. PMID: 30659496
The Open Access license, which previously read.
8.
Sangroongruangsri S, Chaikledkaew U, Kumluang S, Wu O, Geue C, Ratanapakorn T, et al.
Clin Drug Investig . 2018 Aug; 38(9):853-865. PMID: 30069864
Background: There is very limited evidence examining serious systemic adverse events (SSAEs) and post-injection endophthalmitis of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) treatments in Thailand and low- and middle-income...
9.
Pattanaphesaj J, Thavorncharoensap M, Ramos-Goni J, Tongsiri S, Ingsrisawang L, Teerawattananon Y
Expert Rev Pharmacoecon Outcomes Res . 2018 Jun; 18(5):551-558. PMID: 29958008
Background: At present, health technology assessment (HTA) guidelines of many countries including Thailand have recommended EQ-5D as the preferred method for assessing utility. This study aims to generate an EQ-5D-5L...
10.
Khiaocharoen O, Pannarunothai S, Riewpaiboon W, Ingsrisawang L, Teerawattananon Y
Value Health Reg Issues . 2018 Apr; 1(1):29-35. PMID: 29702822
Objective: Rehabilitation can restore function and prevent permanent disability in patients with stroke. There is, however, only one study on cost-effectiveness of rehabilitation in Thailand. Our objective was to evaluate...